Why the study?
How have public health and personalized approaches impacted cardiovascular disease mortality in Japan?
How have public health and personalized approaches impacted cardiovascular disease mortality in Japan?
Public health initiatives targeting blood pressure and smoking have driven significant declines in cardiovascular mortality in Japan, though rising dyslipidemia and diabetes pose future risks.
Supports prioritizing BP and smoking control; leaves open effects of rising dyslipidemia and diabetes on future CVD mortality.
There has been a substantial decline in mortality from stroke and ischemic heart disease (IHD) in Japan between the 1960s and 2000s, which contributed to placing Japanese at the top of world's life expectancy rankings. That mortality decline was attributable to reductions of blood pressure and smoking, in spite of increases in dyslipidemia and diabetes mellitus. The combination of public health and personalized treatment activities to enhance sodium reduction, balanced diets, smoking prevention/cessation as well as hypertension detection and treatment have contributed to the reduction of cardiovascular diseases, demonstrated by a community-based stroke prevention program. The health success story, however, contains an underlying concern about future health threats, the plateaued IHD mortality decline and increased IHD incidence among urban middle-aged men, probably due to increased dyslipidemia and diabetes. The IHD incidence and mortality trends need to be monitored because of a potential future problem for predictive, preventive and personalized medicine.
No takes yet. Share an insight, caveat, or question.
Hiroyasu Iso (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: